News|Articles|December 13, 2023
Harnessing cell line engineering capabilities to enhance biotherapeutic products
Author(s)Revvity
Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.
Related Content
Trending on Pharmaceutical Technology
1
Shilpa CDMO to Launch as Dedicated Complex Small-Molecule Contract Development and Manufacturing Brand at CPHI Milan
2
Assessment of Silicone Oil Cleaning on Indirect Surfaces in Aseptic Manufacturing
3
Technology Transfer: Success Drivers and Obstacles Explained
4
PharmTech Weekly Roundup—September 11, 2026
5